Cizzle Biotechnology Holdings PLC (CIZ) - Cash Flow Conversion Efficiency

Latest as of June 2025: 1.199x

Based on the latest financial reports, Cizzle Biotechnology Holdings PLC (CIZ) has a cash flow conversion efficiency ratio of 1.199x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-331.00K ≈ $-40.27 USD) by net assets (GBX-276.00K ≈ $-33.58 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Cizzle Biotechnology Holdings PLC to measure how many days the company can operate on defensive assets alone.

Cizzle Biotechnology Holdings PLC - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Cizzle Biotechnology Holdings PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Cizzle Biotechnology Holdings PLC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cizzle Biotechnology Holdings PLC ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Mosman Oil and Gas Ltd LSE:MSMN	-0.118x
Akoustis Technologies, Inc. NASDAQ:AKTSQ	0.187x
SCANDION ONC. DK-0735 F:8VY	N/A
QuiaPEG Pharmaceuticals Holding AB ST:QUIA	-0.115x
Cerinnov Group SA PA:ALPCV	0.999x
LORDS CO. WORLDW. HOLD. F:4XM	N/A
IMAC Holdings Inc NASDAQ:BACK	0.228x
Zoo Digital Group Plc LSE:ZOO	0.019x

Annual Cash Flow Conversion Efficiency for Cizzle Biotechnology Holdings PLC (2006–2024)

The table below shows the annual cash flow conversion efficiency of Cizzle Biotechnology Holdings PLC from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see Cizzle Biotechnology Holdings PLC (CIZ) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	GBX82.00K ≈ $9.98	GBX-358.00K ≈ $-43.56	-4.366x	-929.63%
2023-12-31	GBX1.51 Million ≈ $183.36	GBX-639.00K ≈ $-77.75	-0.424x	-28.37%
2022-12-31	GBX2.64 Million ≈ $321.21	GBX-872.00K ≈ $-106.10	-0.330x	+69.33%
2021-12-31	GBX937.00K ≈ $114.01	GBX-1.01 Million ≈ $-122.77	-1.077x	+88.28%
2020-12-31	GBX32.00K ≈ $3.89	GBX-294.00K ≈ $-35.77	-9.188x	-761.46%
2019-12-31	GBX6.63K ≈ $0.81	GBX-7.07K ≈ $-0.86	-1.067x	-148.86%
2018-12-31	GBX-235.00K ≈ $-28.59	GBX-513.00K ≈ $-62.42	2.183x	+951.36%
2017-12-31	GBX741.00K ≈ $90.16	GBX-190.00K ≈ $-23.12	-0.256x	-401.49%
2016-12-31	GBX2.19 Million ≈ $266.09	GBX186.00K ≈ $22.63	0.085x	+135.88%
2015-12-31	GBX2.40 Million ≈ $292.62	GBX-570.00K ≈ $-69.35	-0.237x	-127.41%
2014-12-31	GBX5.05 Million ≈ $614.07	GBX-526.00K ≈ $-64.00	-0.104x	+34.38%
2013-12-31	GBX4.27 Million ≈ $519.41	GBX-678.00K ≈ $-82.49	-0.159x	-424.98%
2012-12-31	GBX4.79 Million ≈ $583.17	GBX-145.00K ≈ $-17.64	-0.030x	+91.82%
2011-12-31	GBX4.08 Million ≈ $496.90	GBX-1.51 Million ≈ $-183.72	-0.370x	-329.38%
2010-12-31	GBX3.54 Million ≈ $430.96	GBX-305.00K ≈ $-37.11	-0.086x	+70.09%
2009-12-31	GBX521.00K ≈ $63.39	GBX-150.00K ≈ $-18.25	-0.288x	+69.03%
2008-12-31	GBX1.67 Million ≈ $202.70	GBX-1.55 Million ≈ $-188.47	-0.930x	-6.47%
2007-12-31	GBX2.40 Million ≈ $291.89	GBX-2.10 Million ≈ $-254.90	-0.873x	-104.62%
2006-12-31	GBX-58.00K ≈ $-7.06	GBX-1.10 Million ≈ $-133.47	18.914x	--

About Cizzle Biotechnology Holdings PLC

LSE:CIZ UK Biotechnology

Market Cap

$135.04K

GBX1.11 Billion GBX

Market Cap Rank

#31201 Global

#1067 in UK

Share Price

GBX2.80

Change (1 day)

-1.75%

52-Week Range

GBX1.29 - GBX3.65

All Time High

GBX1144.91